Fungi@MANCHESTER | Working Together to Beat Fungal Infection

Why?

How many
are affected?

Treating and caring for patients with fungal diseases is becoming an increasing economic burden. Estimated numbers of patients who will need expensive antifungal drugs for some of the life-threatening fungal illnesses are summarised here.

Invasive aspergillosis kills more than 100 000 per year, mortality is >50%
Around 10% of new leukaemic cases will go on to develop invasive aspergillosis (30 000 per year)
54,000 stem cell transplants are carried out annually. 5,400 will get aspergillosis
216 000 COPD patients will need treatment for aspergillosis
Chronic pulmonary aspergillosis causes more than 450 000 deaths per year
Severe asthma kills 100 000 per year, half of which are related to fungal sensitisation

Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA).

Submitted by F@Manc on January 01, 2014

0 comment(s)

K. Al-Shair, Muldoon, E. G., Morris, J., Atherton, G. T., Kosmidis, C., and Denning, D. W., “Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA).”, Respir Med, vol. 114, pp. 117-22, 2016.

Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence.

Submitted by F@Manc on January 01, 2014

0 comment(s)

R. O. Oladele, Akanmu, A. S., Nwosu, A. O., Ogunsola, F. T., Richardson, M. D., and Denning, D. W., “Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence.”, Open Forum Infect Dis, vol. 3, no. 2, p. ofw055, 2016.

Electrophilic, Activation-Free Fluorogenic Reagent for Labeling Bioactive Amines.

Submitted by F@Manc on January 01, 2014

0 comment(s)

M. Sintes, De Moliner, F., Caballero-Lima, D., Denning, D. W., Read, N. D., Kielland, N., Vendrell, M., and Lavilla, R., “Electrophilic, Activation-Free Fluorogenic Reagent for Labeling Bioactive Amines.”, Bioconjug Chem, vol. 27, no. 6, pp. 1430-4, 2016.

Research.

Manchester Fungal Infection Group, National Aspergillosis Centre, Mycology Reference Centre all carry out research programs.

The Manchester Fungal Infection Group (MFIG) is

National Aspergillosis Centre, Mycology Reference Centre Manchester

The UK National Aspergillosis Centre has been commissioned (2009) by the Department of Health to provide long term

PhD, training workshops, internships, Microfungi.net

Many opportunities for training and learning are available from fungi@MANCHESTER

What.

Who.

Where.

Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA).

Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence.

Electrophilic, Activation-Free Fluorogenic Reagent for Labeling Bioactive Amines.

Pages

Research.

Manchester Fungal Infection Group, National Aspergillosis Centre, Mycology Reference Centre all carry out research programs.

Medicine.

National Aspergillosis Centre, Mycology Reference Centre Manchester

Teaching.

PhD, training workshops, internships, Microfungi.net